Scroll To Top

Inflammation From HIV Meds May Lead to Diabetes

Inflammation From HIV Meds May Lead to Diabetes


A new study shows that inflammation can lead to another chronic condition.

A new study has identified low-grade systemic inflammation as an underlying factor in the development of type 2 diabetes among HIV-positive people on antiretroviral medications. Researchers who published their findings in the Journal of Acquired Immune Deficiency Syndromes examined the relationship between the preexistence of inflammatory markers and new type 2 diabetes diagnoses among approximately 3,700 people in the Strategies for Management of Antiretroviral Therapy and ESPRIT HIV treatment studies.

The study subjects were all taking antiretrovirals continuously without additional adjunct therapy. Those who developed diabetes had significantly higher baseline levels of two inflammatory markers (including high-sensitivity C-reactive protein) than those who did not develop the disease. In addition, those who had higher body mass indexes, were older, had coinfections with hepatitis B or hepatitis C, or used lipid-lowering medication also had higher overall rates of diabetes diagnoses.

Out Subscription Lil Nas XAdvocateChannel promotion

From our Sponsors

Most Popular

Fifth Person Cured of HIV

Be sure to follow Plus on your favorite social platforms!


Want more news, top stories, and videos? Check out the all NEW Advocate Channel!
Your 24/7 streaming source for equality news and lifestyle trends.
Click this link right now:

Latest Stories